Santen Pharmaceutical Co (MEX:4536N) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4536N Santen Pharmaceutical Co Ltd MEX:4536N
80 GF Score
Price MXN339.23
GF Value MXN299.21
View Full Analysis

What is Santen Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:4536N vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santen Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Short Interest falls into.


MEX:4536N
80GF Score
Santen Pharmaceutical Co Ltd MEX:4536N
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Santen Pharmaceutical Co (MEX:4536N) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN339.23 is trading 13.4% above its estimated GF Value™ of MXN299.21.

Key valuation signals for MEX:4536N:

  • Short Interest:
  • GF Value™: MXN299.21 vs. price of MXN339.23 (13.4% above fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the MEX:4536N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
80GF Score

Get the complete analysis for MEX:4536N

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN339.23
Price
MXN299.21
GF Value